Literature DB >> 20466556

Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.

Delphine Lamoral-Theys1, Laurent Pottier, Frédéric Kerff, François Dufrasne, Fabien Proutière, Nathalie Wauthoz, Philippe Neven, Laurent Ingrassia, Pierre Van Antwerpen, Florence Lefranc, Michel Gelbcke, Bernard Pirotte, Jean-Louis Kraus, Jean Nève, Alexander Kornienko, Robert Kiss, Jacques Dubois.   

Abstract

A series of 33 novel divanillates and trivanillates were synthesized and found to possess promising cytostatic rather than cytotoxic properties. Several compounds under study decreased by >50% the activity of Aurora A, B, and C, and WEE1 kinase activity at concentrations <10% of their IC(50) growth inhibitory ones, accounting, at least partly, for their cytostatic effects in cancer cells and to a lesser extent in normal cells. Compounds 6b and 13c represent interesting starting points for the development of cytostatic agents to combat cancers, which are naturally resistant to pro-apoptotic stimuli, including metastatic malignancies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466556      PMCID: PMC4966668          DOI: 10.1016/j.bmc.2010.04.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  55 in total

1.  "Promiscuous" anticancer drugs that hit multiple targets may thwart resistance.

Authors:  Tracy Hampton
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

Review 2.  Natural occurring polyphenols as template for drug design. Focus on serine proteases.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Laura Bonfili; Valentina Cecarini; Anna Maria Eleuteri; Mauro Angeletti
Journal:  Chem Biol Drug Des       Date:  2009-07       Impact factor: 2.817

3.  Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.

Authors:  K H Baggaley; R Fears; R M Hindley; B Morgan; E Murrell; D E Thorne
Journal:  J Med Chem       Date:  1977-11       Impact factor: 7.446

4.  Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration.

Authors:  Carine Delbrouck; Isabelle Doyen; Nathalie Belot; Christine Decaestecker; Rose Ghanooni; Aurore de Lavareille; Herbert Kaltner; Georges Choufani; André Danguy; Guy Vandenhoven; Hans-Joachim Gabius; Sergio Hassid; Robert Kiss
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

5.  Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.

Authors:  Delphine Lamoral-Theys; Anna Andolfi; Gwendoline Van Goietsenoven; Alessio Cimmino; Benjamin Le Calvé; Nathalie Wauthoz; Véronique Mégalizzi; Thierry Gras; Céline Bruyère; Jacques Dubois; Véronique Mathieu; Alexander Kornienko; Robert Kiss; Antonio Evidente
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

6.  Understanding melanoma signaling networks as the basis for molecular targeted therapy.

Authors:  Keiran S M Smalley
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

Review 7.  Plant polyphenols and tumors: from mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments.

Authors:  L G Korkina; C De Luca; V A Kostyuk; S Pastore
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 8.  Wee1-dependent mechanisms required for coordination of cell growth and cell division.

Authors:  Douglas R Kellogg
Journal:  J Cell Sci       Date:  2003-12-15       Impact factor: 5.285

9.  Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.

Authors:  Peter Jun; Chibo Hong; Anita Lal; Judith M Wong; Michael W McDermott; Andrew W Bollen; Christoph Plass; William A Held; Dominic J Smiraglia; Joseph F Costello
Journal:  Neuro Oncol       Date:  2008-11-11       Impact factor: 12.300

10.  The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment.

Authors:  Véronique Mathieu; Christine Pirker; Elisabeth Martin de Lassalle; Mathieu Vernier; Tatjana Mijatovic; Nancy DeNeve; Jean-François Gaussin; Mischael Dehoux; Florence Lefranc; Walter Berger; Robert Kiss
Journal:  J Cell Mol Med       Date:  2009-02-20       Impact factor: 5.310

View more
  9 in total

1.  JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation.

Authors:  Céline Bruyère; Sébastien Madonna; Gwendoline Van Goietsenoven; Véronique Mathieu; Jean Dessolin; Jean-Louis Kraus; Florence Lefranc; Robert Kiss
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Authors:  Nathalie Wauthoz; Philippe Deleuze; Amandine Saumet; Christophe Duret; Robert Kiss; Karim Amighi
Journal:  Pharm Res       Date:  2010-11-30       Impact factor: 4.200

3.  Structural simplification of bioactive natural products with multicomponent synthesis. 3. Fused uracil-containing heterocycles as novel topoisomerase-targeting agents.

Authors:  Nikolai M Evdokimov; Severine Van Slambrouck; Petra Heffeter; Lee Tu; Benjamin Le Calvé; Delphine Lamoral-Theys; Carla J Hooten; Pavel Y Uglinskii; Snezna Rogelj; Robert Kiss; Wim F A Steelant; Walter Berger; Jeremy J Yang; Cristian G Bologa; Alexander Kornienko; Igor V Magedov
Journal:  J Med Chem       Date:  2011-03-09       Impact factor: 7.446

4.  A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.

Authors:  Aida Oliván-Viguera; Marta Sofía Valero; Nicole Coleman; Brandon M Brown; Celia Laría; María Divina Murillo; José A Gálvez; María D Díaz-de-Villegas; Heike Wulff; Ramón Badorrey; Ralf Köhler
Journal:  Mol Pharmacol       Date:  2014-12-02       Impact factor: 4.436

5.  Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.

Authors:  Ramesh Dasari; Annelise De Carvalho; Derek C Medellin; Kelsey N Middleton; Frédéric Hague; Marie N M Volmar; Liliya V Frolova; Mateus F Rossato; Jorge J De La Chapa; Nicholas F Dybdal-Hargreaves; Akshita Pillai; Roland E Kälin; Véronique Mathieu; Snezna Rogelj; Cara B Gonzales; João B Calixto; Antonio Evidente; Mathieu Gautier; Gnanasekar Munirathinam; Rainer Glass; Patricia Burth; Stephen C Pelly; Willem A L van Otterlo; Robert Kiss; Alexander Kornienko
Journal:  Eur J Med Chem       Date:  2015-08-29       Impact factor: 6.514

6.  Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.

Authors:  Ramesh Dasari; Marco Masi; Romana Lisy; Marlène Ferdérin; Lance R English; Alessio Cimmino; Véronique Mathieu; Andrew J Brenner; John G Kuhn; Steven T Whitten; Antonio Evidente; Robert Kiss; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2015-08-24       Impact factor: 2.823

7.  Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release.

Authors:  Delphine Lamoral-Theys; Nathalie Wauthoz; Petra Heffeter; Véronique Mathieu; Utte Jungwirth; Florence Lefranc; Jean Nève; Jacques Dubois; François Dufrasne; Karim Amighi; Walter Berger; Philippe Gailly; Robert Kiss
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

8.  A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy.

Authors:  Dinglong Yang; Hetong Li; Yujing Chen; Chunjiang Li; Weiping Ren; Yongbo Huang
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

9.  Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.

Authors:  Aida Oliván-Viguera; Marta Sofía Valero; María Divina Murillo; Heike Wulff; Angel-Luis García-Otín; José-Miguel Arbonés-Mainar; Ralf Köhler
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.